Alpha 2.0
Login Register
» Articles » PMID: 33080647

Cost-effectiveness Analysis of SARS-CoV-2 Infection Prevention Strategies Including Pre-endoscopic Virus Testing and Use of High Risk Personal Protective Equipment

Overview
Journal Endoscopy
Specialties Gastroenterology
Pharmacology
Radiology
Date 2020 Oct 20
PMID 33080647
Citations 13
Authors
Alanna Ebigbo
Christoph Rommele
Christina Bartenschlager
Selin Temizel
Elisabeth Kling
Jens Brunner
Helmut Messmann
Affiliations
Soon will be listed here.
Abstract

Background: Infection prevention strategies to protect healthcare workers in endoscopy units during the post-peak phase of the COVID-19 pandemic are currently under intense discussion. In this paper, the cost-effectiveness of routine pre-endoscopy testing and high risk personal protective equipment (PPE) is addressed.

Method: A model based on theoretical assumptions of 10 000 asymptomatic patients presenting to a high volume center was created. Incremental cost-effectiveness ratios (ICERs) and absolute costs per endoscopy were calculated using a Monte Carlo simulation.

Results: ICER values for universal testing decreased with increasing prevalence rates. For higher prevalence rates (≥ 1 %), ICER values were lowest for routine pre-endoscopy testing coupled with use of high risk PPE, while cost per endoscopy was lowest for routine use of high risk PPE without universal testing.

Conclusion: In general, routine pre-endoscopy testing combined with high risk PPE becomes more cost-effective with rising prevalence rates of COVID-19.

Citing Articles

Cost of the COVID-19 pandemic versus the cost-effectiveness of mitigation strategies in EU/UK/OECD: a systematic review.

Vardavas C, Zisis K, Nikitara K, Lagou I, Marou V, Aslanoglou K BMJ Open. 2023; 13(10):e077602.

PMID: 37907290 PMC: 10619092. DOI: 10.1136/bmjopen-2023-077602.

Economic evaluation of strategies against coronavirus: a systematic review.

Izadi R, Hatam N, Baberi F, Yousefzadeh S, Jafari A Health Econ Rev. 2023; 13(1):18.

PMID: 36933043 PMC: 10024293. DOI: 10.1186/s13561-023-00430-1.

Comparing swab- and different symptoms-based strategies to ascertain COVID-19 recovery in healthcare workers: a cost-effectiveness analysis.

Benoni R, Campagna I, Moretti F, Tardivo S Cost Eff Resour Alloc. 2022; 20(1):50.

PMID: 36096794 PMC: 9465662. DOI: 10.1186/s12962-022-00385-w.

Economic evaluations of interventions against viral pandemics: a scoping review.

Rasmussen M, Kronborg C, Fasterholdt I, Kidholm K Public Health. 2022; 208:72-79.

PMID: 35724446 PMC: 9212686. DOI: 10.1016/j.puhe.2022.05.001.

Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies.

Zhou L, Yan W, Li S, Yang H, Zhang X, Lu W J Glob Health. 2022; 12:05022.

PMID: 35712857 PMC: 9196831. DOI: 10.7189/jogh.12.05022.

References
1.
Gudbjartsson D, Helgason A, Jonsson H, Magnusson O, Melsted P, Norddahl G . Spread of SARS-CoV-2 in the Icelandic Population. N Engl J Med. 2020; 382(24):2302-2315. PMC: 7175425. DOI: 10.1056/NEJMoa2006100. View
2.
Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S, Hayashi K . Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis. 2020; 94:154-155. PMC: 7270890. DOI: 10.1016/j.ijid.2020.03.020. View
3.
Gupta S, Shahidi N, Gilroy N, Rex D, Burgess N, Bourke M . Proposal for the return to routine endoscopy during the COVID-19 pandemic. Gastrointest Endosc. 2020; 92(3):735-742. PMC: 7187831. DOI: 10.1016/j.gie.2020.04.050. View
4.
Gralnek I, Hassan C, Beilenhoff U, Antonelli G, Ebigbo A, Pellise M . ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: An update on guidance during the post-lockdown phase and selected results from a membership survey. Endoscopy. 2020; 52(10):891-898. PMC: 7520543. DOI: 10.1055/a-1213-5761. View
5.
Thompson C, Shen L, Lee L . COVID-19 in endoscopy: Time to do more?. Gastrointest Endosc. 2020; 92(2):435-439. PMC: 7146697. DOI: 10.1016/j.gie.2020.03.3848. View